| Net income including noncontrolling interests | 25.71M |
| Depreciation and amortization | 6.21M |
| Provision for doubtful accounts | 2.96M |
| Equity-based awards compensation expense | 3.75M |
| (Gain) loss on sale of business and sale or abandonment of assets, net | |
| Deferred income tax | 5.69M |
| Other | 0 |
| Increase in patient accounts receivable | |
| Increase in accounts receivable - other | |
| Increase in other assets | -4.98M |
| Decrease in accounts payable and accrued expenses | 5.18M |
| Increase in other liabilities | 708K |
| Net cash provided by operating activities | |
| Purchase of fixed assets | -5.62M |
| Purchase of businesses, net of cash acquired | -12.96M |
| Acquisitions of noncontrolling interests | |
| Net proceeds on sale of fixed assets and business | 42K |
| Net cash used in investing activities | |
| Distributions to noncontrolling interests | -8.27M |
| Cash dividends to shareholders | -6.38M |
| Proceeds from revolving line of credit | 128M |
| Payments on revolving line of credit | -136M |
| Payment of notes payable | -592K |
| Excess tax benefit from stock options exercised | |
| Proceeds from exercise of stock options | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash | -754K |
| Cash - beginning of period | |
| Cash - end of period | |
| Income taxes | 10.05M |
| Interest | 770K |
| Purchase of business - seller financing portion | 514K |
| Acquisition of noncontrolling interest - seller financing portion | |